Key marijuana drug approval looms as cannabis goes mainstream …

LONDON (Reuters) – Evidence that cannabis can ease epilepsy and other conditions is building as a British company counts down to what would be the first U.S. government approval for a prescription drug derived from the marijuana plant.

FILE PHOTO: Charlotte Caldwell, and her son Billy, sit outside the Home Office during a break in a meeting with officials to discuss how Billy can have his severe epilepsy treated with cannabis oil, which is a banned substance in Britain, in London, June 11, 2018. REUTERS/Peter Nicholls/File Photo

GW Pharmaceuticals, which has spent 20 years developing medicines from cannabis, is hoping for a Food and Drug Administration (FDA) green light by June 27, after winning support from an advisory panel in April.

Some parents already use cannabis to help children with severe forms of epilepsy, but such therapy is not monitored or licensed.

Scientists told a briefing in London on

... read more at: https://www.reuters.com/article/us-health-cannabis/key-marijuana-drug-approval-looms-as-cannabis-goes-mainstream-idUSKBN1JH2H2